In the wake of the slice wars, which saw CT scanners boom from four to 320 slices, a new battle will be fought, one focused on energy and spectral imaging. Photon counting, triple- and quad-energy systems, and a new breed of contrast agents are emerging drivers in the development of spectral CT, say some experts in topics scheduled for the Tuesday, May 18, ISCT session on Dual Energy and Spectral Imaging.
In the wake of the slice wars, which saw CT scanners boom from four to 320 slices, a new battle will be fought, one focused on energy and spectral imaging. Photon counting, triple- and quad-energy systems, and a new breed of contrast agents are emerging drivers in the development of spectral CT, say some experts in topics scheduled for the Tuesday, May 18, ISCT session on Dual Energy and Spectral Imaging.
Today’s technology, dual-energy CT, which applies high- and low-power x-rays, is a first step. Willi Kalender, Ph.D., a professor in the Institute of Medical Physics at the University of Erlangen in Germany, will examine how cadmium telluride might allow the next step. Advantages and disadvantages of CdTe detectors, specifically their potential as the means to achieve CT photon counting, will be compared with those of conventional detectors.
Technical challenges will likely give way to multienergy CT systems. Vendors now pursuing photon-counting technologies are separating the x-ray spectrum into different energy levels, so-called “energy bins.” Dr. Jacob Sosna, CT director of research and imaging laboratories at Hadassah Hebrew University Medical Center in Jerusalem, will describe how these early efforts might evolve, presenting information about a prototypical human scanner being developed at the Rabin Medical Center in Israel.
Some pundits believe adoption will come only in specialty systems, such as ones developed for breast CT. Others see their potential in general-purpose scanners that are applied to a wide range of specialty applications. Cardiovascular applications are the leading candidates, such as the diagnosis of pulmonary embolism and assessment of myocardial perfusion. Dr. Jean Louis Sablayrolles, chief of the CT and MRI department of the Centre Cardiologique du Nord in Saint Denis, France, will present initial clinical results using spectral imaging to characterize and visualize blood vessels, pulmonary emboli, and lumen heavily calcified with plaques or repaired using stents. He will also examine how spectral imaging might fit into oncology, specifically the characterization of lesions.
Dual-energy CT might quantify calcium through its ability to overcome a substantial shortcoming of conventional CT. Calcium scoring currently is done without contrast enhancement because iodine and calcium are both radio-opaque and indistinguishable on single-energy CT systems. Sandra Simon Halliburton, Ph.D., a cardiac imaging scientist in the Cardiovascular Imaging Laboratory of the Cleveland Clinics, will present data showing how dual-energy CT might be used to exactly quantify plaque burden by distinguishing calcium from iodine, thereby creating “virtual noncontrast images.”
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
AMA Approves Category III CPT Codes for AI-Enabled Perivascular Fat Analysis from CT Scans
April 9th 2025Going into effect in 2026, the new CPT codes may facilitate increased adoption of the CaRi-Heart software for detecting coronary inflammation from computed tomography scans pending FDA clearance of the technology.
FDA Clears AI Assessment of Ischemic Core Volume on CT with Brainomix 360 Platform
April 8th 2025For patients with acute ischemic stroke, research has demonstrated that automated assessment of ischemic core volume on brain CT scans via the Brainomix 360 software is equivalent to that derived from CT perfusion.